2023-04-07 |
108 |
Opinion - Memorandum Opinion |
pharmaceutically acceptable excipients.
U.S. Patent No. 8,206,740 cl. 1.
Sun already construed the terms…company, Sun, for infringing the same patents.
Many of the patents’ terms were construed in that suit. … slowly. Galderma patented its developments.
Though Galderma has several patents and dozens of claims… “It is a bedrock principle of patent law that the claims of a patent define the in-
vention to which…Galderma says Lupin infringes some of its drug patents. A few years ago, Gal-
derma won a lawsuit against |
External link to document |
2023-04-07 |
109 |
Order |
ORDER Regarding Terms of US Patent Nos. 7,749,532; 8,206,740; 8,394,405; 8,394,406; 8,470,364; …2021
1 April 2024
1:21-cv-01710
835 Patent - Abbreviated New Drug Application(ANDA)
Defendant |
External link to document |
2023-05-10 |
116 |
Stipulation of Dismissal |
of Claims and Defenses Relating to U.S. Patent Nos. 8,394,405, 8,394,406, 8,470,364, and 8,709,478 by …2021
1 April 2024
1:21-cv-01710
835 Patent - Abbreviated New Drug Application(ANDA)
Defendant |
External link to document |
2023-05-11 |
118 |
|
of Claims and Defenses Relating to U.S. Patent Nos. 8,394,405, 8,394,406, 8,470,364, and 8,709,478. Ordered…2021
1 April 2024
1:21-cv-01710
835 Patent - Abbreviated New Drug Application(ANDA)
Defendant |
External link to document |
2023-06-08 |
121 |
Notice of Service |
Regarding Lupin's Infringement of U.S. Patent Nos. 7,749,532 and 8,206,740 filed by Galderma Laboratories…2021
1 April 2024
1:21-cv-01710
835 Patent - Abbreviated New Drug Application(ANDA)
Defendant |
External link to document |
2024-03-22 |
197 |
Opinion - Memorandum Opinion |
several
patents for a once-daily doxycycline capsule. See U.S. Patent No. 7,749,532; U.S.
Patent No. 8,…I reject its patent-infringement claim.
I. GALDERMA SUES LUPIN FOR PATENT INFRINGEMENT…8,206,740. Together, the ’532 and ’740 patents are called the Chang patents.
Tr. 13:12–14. And the commercial…claims 1 and 16 of the ’532 patent plus claims 1 and 20 of the
’740 patent. Tr. 79:11–14. Though the full…the Chang patents. Tr. 78:1–6. He began by describing the
relevant practitioner for patent-infringement |
External link to document |
2021-12-03 |
4 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,749,532 B2 ;8,206,740 B2 ;8,394,405…2021
1 April 2024
1:21-cv-01710
835 Patent - Abbreviated New Drug Application(ANDA)
Defendant |
External link to document |